Navigating veterans with an abnormal prostate cancer screening test: A quasi-experimental study

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Simon, Melissa A ^a   Nonzee, Narissa J ^a,b   McKoy, June M ^a   Liu, Dachao ^a,b   Luu, Thanh Ha ^c   Byer, Peter ^a,b   Eklund, Elizabeth A ^a,b   Richey, Elizabeth A ^d   Wu, Zhigang ^b,e   Dong, Xinqi ^c   Rademaker, Alfred W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BLOOD; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PROCEDURES; PROSTATIC NEOPLASMS; PUBLIC HOSPITAL; SOCIAL WORK; TIME FACTOR; UNITED STATES; VERY ELDERLY; VETERAN;

ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; PATIENT NAVIGATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SOCIAL WORK; TIME FACTORS; UNITED STATES; VETERANS;

MLCS; MLOWN;

EID: 84881453231     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-314     Document Type: Article

References (39)

1. Cancer statistics, 2013. Siegel R, Naishadham D, Jemal A, CA Cancer J Clin 2013 63 1 11 30 10.3322/caac.21166 23335087
2. Cancer treatment and survivorship statistics, 2012. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al. CA Cancer J Clin 2012 62 4 220 241 10.3322/caac.21149 22700443
3. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national longitudinal mortality study. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, Goodman MT, Lynch CF, Schwartz SM, Chen VW, et al. Cancer Causes Control 2009 20 4 417 435 10.1007/s10552-008-9256-0 19002764
4. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, et al. SEER Cancer Statistics Review, 1975-2010 2012 [ http://seer.cancer.gov/csr/1975-2010/ ]
5. Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Talcott JA, Spain P, Clark JA, Carpenter WR, Do YK, Hamilton RJ, Galanko JA, Jackman A, Godley PA, Cancer 2007 109 8 1599 1606 10.1002/cncr.22583 17354220 (Pubitemid 46595696)
6. Perceptions of prostate cancer in Black African and Black Caribbean men: a systematic review of the literature. Pedersen VH, Armes J, Ream E, Psychooncology 2012 21 5 457 468 10.1002/pon.2043 21905156
7. Racial and geographic disparities in late-stage prostate cancer diagnosis in Florida. Xiao H, Tan F, Goovaerts P, J Health Care Poor Underserved 2011 22 4 Suppl 187 199 22102314
8. Uncovering myths and transforming realities among low-SES African-American men: implications for reducing prostate cancer disparities. Richardson JT, Webster JD, Fields NJ, J Natl Med Assoc 2004 96 10 1295 1302 15540880 (Pubitemid 39318957)
9. Prevalence of delayed clinician response to elevated prostate-specific antigen values. Nepple KG, Joudi FN, Hillis SL, Wahls TL, Mayo Clin Proc 2008 83 4 439 445 10.4065/83.4.439 18380989 (Pubitemid 351536469)
10. Knowledge, beliefs and barriers associated with prostate cancer prevention and screening behaviors among African-American men. Blocker DE, Romocki LS, Thomas KB, Jones BL, Jackson EJ, Reid L, Campbell MK, J Natl Med Assoc 2006 98 8 1286 1295 16916126 (Pubitemid 44167753)
11. Patient navigation: state of the art or is it science? Wells KJ, Battaglia TA, Dudley DJ, Garcia R, Greene A, Calhoun E, Mandelblatt JS, Paskett ED, Raich PC, Cancer 2008 113 8 1999 2010 10.1002/cncr.23815 18780320
12. Expanding access to cancer screening and clinical follow-up among the medically underserved. Freeman HP, Muth BJ, Kerner JF, Cancer Pract 1995 3 1 19 30 7704057
13. National cancer institute patient navigation research program: methods, protocol, and measures. Freund KM, Battaglia TA, Calhoun E, Dudley DJ, Fiscella K, Paskett E, Raich PC, Roetzheim RG, Cancer 2008 113 12 3391 3399 10.1002/cncr.23960 18951521
14. Boston patient navigation research program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Battaglia TA, Bak SM, Heeren T, Chen CA, Kalish R, Tringale S, Taylor JO, Lottero B, Egan AP, Thakrar N, et al. Cancer Epidemiol Biomarkers Prev 2012 21 10 1645 1654 10.1158/1055-9965.EPI-12-0532 23045539
15. Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. Dudley DJ, Drake J, Quinlan J, Holden A, Saegert P, Karnad A, Ramirez A, Cancer Epidemiol Biomarkers Prev 2012 21 10 1639 1644 10.1158/1055-9965.EPI-12-0538 23045538
16. Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. Hoffman HJ, LaVerda NL, Young HA, Levine PH, Alexander LM, Brem R, Caicedo L, Eng-Wong J, Frederick W, Funderburk W, et al. Cancer Epidemiol Biomarkers Prev 2012 21 10 1655 1663 10.1158/1055-9965.EPI- 12-0479 23045540
17. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program. Markossian TW, Darnell JS, Calhoun EA, Cancer Epidemiol Biomarkers Prev 2012 21 10 1691 1700 10.1158/1055-9965.EPI-12-0535 23045544
18. The Ohio patient navigation research program: does the American cancer society patient navigation model improve time to resolution in patients with abnormal screening tests? Paskett ED, Katz ML, Post DM, Pennell ML, Young GS, Seiber EE, Harrop JP, DeGraffinreid CR, Tatum CM, Dean JA, et al. Cancer Epidemiol Biomarkers Prev 2012 21 10 1620 1628 10.1158/1055-9965.EPI-12-0523 23045536
19. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Raich PC, Whitley EM, Thorland W, Valverde P, Fairclough D, Cancer Epidemiol Biomarkers Prev 2012 21 10 1629 1638 10.1158/1055-9965.EPI-12-0513 23045537
20. Patient navigation: an update on the state of the science. Paskett ED, Harrop JP, Wells KJ, CA Cancer J Clin 2011 61 4 237 249 10.3322/caac.20111 21659419
21. The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women. Percac-Lima S, Benner CS, Lui R, Aldrich LS, Oo SA, Regan N, Chabner BA, J Womens Health (Larchmt) 2013 22 5 426 431 10.1089/jwh.2012.3900
22. Impact of patient navigation from diagnosis to treatment in an urban safety net breast cancer population. Haideri NA, Moormeier JA, J Cancer 2011 2 467 473 21915191
23. Culturally targeted patient navigation for increasing African American's adherence to screening colonoscopy: a randomized clinical trial. Jandorf L, Braschi C, Ernstoff E, Wong CR, Thelemaque LD, Winkel G, Thompson H, Redd WH, Itzkowitz S, in press
24. Increasing colonoscopy screening for Latino Americans through a patient navigation model: a randomized clinical trial. Braschi CD, Sly JR, Singh S, Villagra C, Jandorf L, J Immigr Minor Health in press
25. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Lasser KE, Murillo J, Lisboa S, Casimir AN, Valley-Shah L, Emmons KM, Fletcher RH, Ayanian JZ, Arch Intern Med 2011 171 10 906 912 10.1001/archinternmed.2011.201 21606094
26. The effect of a lung cancer care coordination program on timeliness of care. Alsamarai S, Yao X, Cain HC, Chang BW, Chao HH, Connery DM, Deng Y, Garla VN, Hunnibell LS, Kim AW, et al. Clin Lung Cancer in press
27. Increasing prostate cancer screening in African American men with peer-educator and client-navigator interventions. Weinrich SP, Boyd MD, Weinrich M, Greene F, Reynolds WA Jr, Metlin C, J Cancer Educ 1998 13 4 213 219 9883780 (Pubitemid 29024726)
28. U.S. Department of Veterans Affairs, National center for veterans analysis and statistics 2011 [ http://www.va.gov/vetdata/ ]
29. Design of a prostate cancer patient navigation intervention for a veterans affairs hospital. Nonzee NJ, McKoy JM, Rademaker AW, Byer P, Luu TH, Liu D, Richey EA, Samaras AT, Panucci G, Dong X, et al. BMC Health Services Res 2012 12 340 10.1186/1472-6963-12-340
30. A national patient navigator training program. Calhoun EA, Whitley EM, Esparza A, Ness E, Greene A, Garcia R, Valverde PA, Health Promot Pract 2010 11 2 205 215 10.1177/1524839908323521 19116415
31. SAS Version 9.2 Cary, N.C: SAS Institute Inc 2008
32. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Charlson ME, Pompei P, Ales KL, MacKenzie CR, J Chronic Dis 1987 40 5 373 383 10.1016/0021-9681(87)90171-8 3558716 (Pubitemid 17055592)
33. Low-income women with abnormal breast findings: results of a randomized trial to increase rates of diagnostic resolution. Bastani R, Mojica CM, Berman BA, Ganz PA, Cancer Epidemiol Biomarkers Prev 2010 19 8 1927 1936 10.1158/1055-9965.EPI-09-0481 20647406
34. Confiding in crisis: gender differences in pattern of confiding among cancer patients. Harrison J, Maguire P, Pitceathly C, Soc Sci Med 1995 41 9 1255 1260 10.1016/0277-9536(94)00411-L 8545678
35. Agreement between administrative data and patients' self-reports of race/ethnicity. Kressin NR, Chang BH, Hendricks A, Kazis LE, Am J Public Health 2003 93 10 1734 1739 10.2105/AJPH.93.10.1734 14534230 (Pubitemid 38477643)
36. Self-reported vs administrative race/ethnicity data and study results. Boehmer U, Kressin NR, Berlowitz DR, Christiansen CL, Kazis LE, Jones JA, Am J Public Health 2002 92 9 1471 1472 10.2105/AJPH.92.9.1471 12197976
37. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Presti JC Jr, Terris MK, J Urol 2006 175 4 1298 1302 discussion 1302-1293 10.1016/S0022-5347(05)00646-4 16515984
38. Screening for prostate cancer: early detection or overdetection? Vickers AJ, Roobol MJ, Lilja H, Annu Rev Med 2012 63 161 170 10.1146/annurev-med-050710- 134421 22053739
39. Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma? Andrews SF, Horwitz EM, Feigenberg SJ, Eisenberg DF, Hanlon AL, Uzzo RG, Pollack A, Cancer 2005 104 2 299 304 10.1002/cncr.21184 15954083 (Pubitemid 40993256)